CN104759242B - A kind of method utilizing yeast synthesis metallic organic framework hollow structure capsule - Google Patents
A kind of method utilizing yeast synthesis metallic organic framework hollow structure capsule Download PDFInfo
- Publication number
- CN104759242B CN104759242B CN201510147358.1A CN201510147358A CN104759242B CN 104759242 B CN104759242 B CN 104759242B CN 201510147358 A CN201510147358 A CN 201510147358A CN 104759242 B CN104759242 B CN 104759242B
- Authority
- CN
- China
- Prior art keywords
- cell wall
- metal
- yeast
- organic framework
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 85
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 30
- 230000015572 biosynthetic process Effects 0.000 title abstract description 14
- 238000003786 synthesis reaction Methods 0.000 title abstract description 14
- 239000013384 organic framework Substances 0.000 title abstract 6
- 210000002421 cell wall Anatomy 0.000 claims abstract description 61
- 238000003756 stirring Methods 0.000 claims abstract description 31
- 239000013110 organic ligand Substances 0.000 claims abstract description 28
- 229910052751 metal Inorganic materials 0.000 claims abstract description 27
- 239000002184 metal Substances 0.000 claims abstract description 27
- 239000000725 suspension Substances 0.000 claims abstract description 23
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 239000012266 salt solution Substances 0.000 claims abstract description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 87
- 239000012621 metal-organic framework Substances 0.000 claims description 40
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 28
- 210000005253 yeast cell Anatomy 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 17
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 15
- 239000002244 precipitate Substances 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000003446 ligand Substances 0.000 claims description 10
- 230000002194 synthesizing effect Effects 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 4
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 claims description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 4
- 229910052723 transition metal Inorganic materials 0.000 claims description 4
- -1 transition metal salt Chemical class 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 229930187593 rose bengal Natural products 0.000 description 17
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 17
- 229940081623 rose bengal Drugs 0.000 description 17
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 17
- 239000008367 deionised water Substances 0.000 description 8
- 229910021641 deionized water Inorganic materials 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- SLCITEBLLYNBTQ-UHFFFAOYSA-N CO.CC=1NC=CN1 Chemical compound CO.CC=1NC=CN1 SLCITEBLLYNBTQ-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- VHKFFPOTSWQHPK-UHFFFAOYSA-N C(C)O.C1(=CC(=CC(=C1)C(=O)O)C(=O)O)C(=O)O Chemical compound C(C)O.C1(=CC(=CC(=C1)C(=O)O)C(=O)O)C(=O)O VHKFFPOTSWQHPK-UHFFFAOYSA-N 0.000 description 1
- 239000013148 Cu-BTC MOF Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- BJMBNXMMZRCLFY-UHFFFAOYSA-N [N].[N].CN(C)C=O Chemical compound [N].[N].CN(C)C=O BJMBNXMMZRCLFY-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011796 hollow space material Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- ZDRJFKKHRONKJQ-UHFFFAOYSA-N n,n-dimethylformamide;terephthalic acid Chemical compound CN(C)C=O.OC(=O)C1=CC=C(C(O)=O)C=C1 ZDRJFKKHRONKJQ-UHFFFAOYSA-N 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- NOSIKKRVQUQXEJ-UHFFFAOYSA-H tricopper;benzene-1,3,5-tricarboxylate Chemical compound [Cu+2].[Cu+2].[Cu+2].[O-]C(=O)C1=CC(C([O-])=O)=CC(C([O-])=O)=C1.[O-]C(=O)C1=CC(C([O-])=O)=CC(C([O-])=O)=C1 NOSIKKRVQUQXEJ-UHFFFAOYSA-H 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
(一)技术领域(1) Technical field
本发明涉及一种金属有机骨架的制备,特别涉及利用酵母菌为支撑合成金属有机骨架-细胞壁胶囊的合成方法。The invention relates to the preparation of a metal-organic framework, in particular to a method for synthesizing a metal-organic framework-cell wall capsule by using yeast as a support.
(二)背景技术(2) Background technology
胶囊通常是指内部为中空的半透过性的球状固体。通常可用于封装,催化,微反应器,检测器,药物缓释等方面。同时可以通过改变胶囊壁的特点对胶囊的半透性能进行调节。然而传统的胶囊的合成方法通常会遇到低效率,难以放大,可控性较差等方面的问题。这些问题在很大程度上限制了胶囊的研究与发展。同时制备胶囊的材料也是各种各样。如聚合物,分子筛,金属有机化合物等都可以用于胶囊的制备。金属有机骨架材料作为一种配位化合物,由金属节点和有机配体通过配位键结合而成,其具有很好的化学稳定性及热稳定性,同时还具有以下特点:巨大的比表面积,微孔或者介孔级别的孔道结构,化学改性的多样性,气体选择吸附性等。因此其被大量的用于吸附/分离,催化,检测器,药物缓释,燃料电池离子隔膜等方面。Capsules generally refer to semi-permeable spherical solids with a hollow interior. It can usually be used in encapsulation, catalysis, microreactors, detectors, drug sustained release, etc. At the same time, the semipermeability of the capsule can be adjusted by changing the characteristics of the capsule wall. However, the traditional synthesis methods of capsules usually encounter problems such as low efficiency, difficulty in scaling up, and poor controllability. These problems limit the research and development of capsules to a large extent. The materials for preparing capsules are also various. Such as polymers, molecular sieves, metal organic compounds, etc. can be used in the preparation of capsules. As a kind of coordination compound, metal organic framework material is composed of metal nodes and organic ligands through coordination bonds. It has good chemical stability and thermal stability, and also has the following characteristics: huge specific surface area, Microporous or mesopore-level pore structure, diversity of chemical modification, gas selective adsorption, etc. Therefore, it is widely used in adsorption/separation, catalysis, detector, drug sustained release, fuel cell ion membrane and so on.
近年来金属有机骨架也被用于胶囊的制备。De Vos等人通过界面合成法得到了Cu-BTC(金属有机骨架的一种)胶囊,并证明了该胶囊具有选择透过性。Maspoch等人通过喷雾干燥法合成了一系列的金属有机骨架胶囊,并将其应用于封装,催化等方面。Wang等人通过在合成液中添加聚维酮合成了纳米级别的金属有机骨架胶囊。然而这些胶囊是无支撑的。由于金属有机骨架的柔韧性较差,且机械性能不是很稳定,因此无支撑的金属有机骨架胶囊在持续使用方面可能会存在缺陷。Metal-organic frameworks have also been used in the preparation of capsules in recent years. De Vos et al. obtained Cu-BTC (a metal-organic framework) capsule by interfacial synthesis, and proved that the capsule has selective permeability. Maspoch et al. synthesized a series of metal-organic framework capsules by spray-drying method and applied them in encapsulation and catalysis. Wang et al. synthesized nanoscale MOF capsules by adding povidone to the synthesis solution. These capsules are however unsupported. Due to the poor flexibility of MOFs and not very stable mechanical properties, unsupported MOF capsules may be disadvantageous in terms of sustained use.
大部分金属有机骨架膜是通过将金属有机骨架生长于基膜上面得到的。因此如果能将金属有机骨架生长于空心球状的基底上,则可以获得有支撑的金属有机骨架胶囊,提高胶囊的稳定性。同时根据金属有机骨架膜制备的条件可知,空心球状的基底应该具有以下特点:1)基底应该具有很好的机械稳定性能。2)基底应该是可透过性的。3)基底应该具有大量的异相成核位点。酵母菌细胞壁作为一种天然的中空材料能够完美的满足以上特点。其作为细胞的最外层保护结构具有优异的机械稳定性和化学稳定性。同时细胞壁近乎具有全透性。再者作为有机生物大分子组成的结构,其具有大量的极性基团,因此在合成有机金属架胶囊的时候其能吸附金属有机骨前体的配体或者金属离子形成异相晶核。这样如果将细胞壁用于金属有机骨架胶囊的制备会大大的提高其使用范围。Most metal-organic framework membranes are obtained by growing metal-organic frameworks on the base membrane. Therefore, if the metal-organic framework can be grown on the hollow spherical substrate, a supported metal-organic framework capsule can be obtained, and the stability of the capsule can be improved. At the same time, according to the preparation conditions of the metal-organic framework membrane, it can be seen that the hollow spherical substrate should have the following characteristics: 1) The substrate should have good mechanical stability. 2) The substrate should be permeable. 3) The substrate should have a large number of heterogeneous nucleation sites. Yeast cell wall, as a natural hollow material, can perfectly meet the above characteristics. As the outermost protective structure of cells, it has excellent mechanical and chemical stability. At the same time, the cell wall is almost completely permeable. Furthermore, as a structure composed of organic biomacromolecules, it has a large number of polar groups, so it can adsorb ligands or metal ions of metal-organic bone precursors to form heterogeneous crystal nuclei when synthesizing organometallic framework capsules. In this way, if the cell wall is used for the preparation of the metal-organic framework capsule, its application range will be greatly improved.
(三)发明内容(3) Contents of the invention
本发明目的是提供一种制备金属有机骨架胶囊的方法,利用酵母菌细胞壁为支撑基底合成金属有机骨架-细胞壁胶囊的合成方法。The object of the present invention is to provide a method for preparing metal organic framework capsules, which is a method for synthesizing metal organic framework-cell wall capsules by using yeast cell walls as supporting substrates.
本发明采用的技术方案是:The technical scheme adopted in the present invention is:
本发明提供一种利用酵母菌合成金属有机骨架中空结构胶囊的方法,所述方法为:(1)取酵母细胞壁悬浮于溶剂中制成细胞壁悬浮液;然后将金属盐或有机配体添加于细胞壁悬浮液中,50-140℃搅拌6-24h(优选50-100℃搅拌12h),离心,取沉淀,获得含有金属离子的细胞壁或含有机配体的细胞壁;所述溶剂为水或有机溶剂;(2)将含有金属离子的细胞壁分散于有机配体盐溶液中,或者将含有机配体的细胞壁分散于金属盐溶液中,50-140℃(优选50-100℃)缓慢搅拌结晶,将结晶后的悬浮液在室温下冷却,离心(优选在5000转/分钟的条件下离心5min),去除上清液,收集沉淀物,即获得金属有机骨架-细胞壁胶囊;对于不同种类的金属有机骨架胶囊的制备,所采用的金属离子和有机配体以及采用的溶剂不同;当含有金属离子的细胞壁分散于有机配体盐溶液时,所合成的金属有机骨架层生长在细胞壁的外表面;当含有有机配体的细胞壁分散于金属盐溶液中时,所合成的金属有机骨架层生长在细胞壁的内表面。The invention provides a method for synthesizing metal-organic framework hollow structure capsules by using yeast. The method is as follows: (1) taking yeast cell walls and suspending them in a solvent to make a cell wall suspension; then adding metal salts or organic ligands to the cell walls In the suspension, stir at 50-140°C for 6-24h (preferably 50-100°C for 12h), centrifuge, and take the precipitate to obtain cell walls containing metal ions or cell walls containing organic ligands; the solvent is water or an organic solvent; (2) Disperse the cell wall containing metal ions in an organic ligand salt solution, or disperse the cell wall containing an organic ligand in a metal salt solution, slowly stir and crystallize at 50-140°C (preferably 50-100°C), and crystallize The final suspension is cooled at room temperature, centrifuged (preferably centrifuged at 5000 rpm for 5min), removes the supernatant, and collects the precipitate to obtain metal organic framework-cell wall capsules; for different types of metal organic framework capsules The preparation of metal ions, organic ligands and solvents used are different; when the cell wall containing metal ions is dispersed in the organic ligand salt solution, the synthesized metal-organic framework layer grows on the outer surface of the cell wall; when containing organic When the liganded cell wall is dispersed in a metal salt solution, the synthesized metal-organic framework layer grows on the inner surface of the cell wall.
进一步,步骤(1)中酵母细胞壁来自啤酒酵母或面包酵母。Further, the yeast cell wall in step (1) is from brewer's yeast or baker's yeast.
进一步,步骤(1)溶剂为下列之一:水、甲醇、乙醇、乙二醇、丙三醇、吡咯烷酮、氮氮二甲基甲酰胺、N,N-二甲基乙酰胺、N,N-二乙基甲酰胺、吡啶、哌啶、呋喃、四氢呋喃、二氧六环或者二甲亚砜。Further, the solvent in step (1) is one of the following: water, methanol, ethanol, ethylene glycol, glycerol, pyrrolidone, nitrogen nitrogen dimethylformamide, N,N-dimethylacetamide, N,N- Diethylformamide, pyridine, piperidine, furan, tetrahydrofuran, dioxane, or dimethylsulfoxide.
进一步,步骤(1)金属盐为过渡金属盐,优选Zn(NO3)2·6H2O、Cu(NO3)2·3H2O和FeCl3·3H2O,所述有机配体盐为羧酸配体或咪唑配体,所述细胞悬浮液中有机配体盐终浓度为20-400mmol/L,优选50-100mmol/L,金属盐终浓度为20-400mmol/L,优选50-100mmol/L。Further, the metal salt in step (1) is a transition metal salt, preferably Zn(NO 3 ) 2 ·6H 2 O, Cu(NO 3 ) 2 ·3H 2 O and FeCl 3 ·3H 2 O, and the organic ligand salt is Carboxylic acid ligand or imidazole ligand, the final concentration of organic ligand salt in the cell suspension is 20-400mmol/L, preferably 50-100mmol/L, and the final concentration of metal salt is 20-400mmol/L, preferably 50-100mmol /L.
进一步,步骤(2)有机配体盐溶液浓度为20-400mmol/L,优选50-100mmol/L,金属盐溶液浓度为20-400mmol/L,优选50-100mmol/L。Further, in step (2), the concentration of the organic ligand salt solution is 20-400mmol/L, preferably 50-100mmol/L, and the concentration of the metal salt solution is 20-400mmol/L, preferably 50-100mmol/L.
此外,本发明还提供一种利用酵母菌合成金属有机骨架中空结构胶囊的方法,所述方法为:将酵母细胞壁分散于金属盐和有机配体用溶剂配制的混合液中,20-100℃搅拌6-24h(优选50-100℃搅拌12h),结晶,将结晶后的悬浮液在室温下冷却,在5000转/分钟的条件下离心5min,去除上清液,收集沉淀物,获得金属有机骨架-细胞壁胶囊;对于不同种类的金属有机骨架胶囊的制备,所采用的金属离子和有机配体以及采用的溶剂不同。该方法所制备的金属有机骨架层生长在细胞壁的外表面。In addition, the present invention also provides a method for synthesizing metal-organic framework hollow structure capsules by using yeast. The method is as follows: disperse the yeast cell wall in the mixed solution prepared by metal salt and organic ligand solvent, and stir at 20-100°C 6-24h (preferably stirred at 50-100°C for 12h), crystallize, cool the crystallized suspension at room temperature, centrifuge at 5000 rpm for 5min, remove the supernatant, collect the precipitate, and obtain a metal-organic framework - Cell wall capsules; for the preparation of different types of metal-organic framework capsules, the metal ions and organic ligands used and the solvents used are different. The metal organic framework layer prepared by the method grows on the outer surface of the cell wall.
进一步,混合液中金属盐终浓度为20-400mmol/L,优选50-100mmol/L,最优选100mmol/L,所述有机配体终浓度为20-400mmol/L,优选50-100mmol/L,最优选100mmol/L。Further, the final concentration of the metal salt in the mixed solution is 20-400mmol/L, preferably 50-100mmol/L, most preferably 100mmol/L, and the final concentration of the organic ligand is 20-400mmol/L, preferably 50-100mmol/L, Most preferably 100mmol/L.
进一步,所述酵母细胞来自啤酒酵母或面包酵母。Further, the yeast cells are from brewer's yeast or baker's yeast.
进一步,所述溶剂为下列之一:水,甲醇,乙醇,乙二醇,丙三醇,吡咯烷酮,N,N-二甲基甲酰胺,N,N-二甲基乙酰胺,N,N-二乙基甲酰胺,吡啶,哌啶,呋喃,四氢呋喃,二氧六环或者二甲亚砜。Further, the solvent is one of the following: water, methanol, ethanol, ethylene glycol, glycerol, pyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, N,N- Diethylformamide, pyridine, piperidine, furan, tetrahydrofuran, dioxane or dimethylsulfoxide.
进一步,金属盐为过渡金属盐,优选Zn(NO3)2·6H2O、FeCl3·6H2O或Cu(NO3)2·6H2O,所述有机配体盐为羧酸配体或咪唑配体。Further, the metal salt is a transition metal salt, preferably Zn(NO 3 ) 2 ·6H 2 O, FeCl 3 ·6H 2 O or Cu(NO 3 ) 2 ·6H 2 O, and the organic ligand salt is a carboxylic acid ligand or imidazole ligands.
本发明所述金属有机骨架系列为:CuBTC(HKUST)系列,ZIF系列,IRMOF系列,MIL系列,PCN系列,FMOF系列或BIO-MOF系列。The metal-organic framework series described in the present invention are: CuBTC (HKUST) series, ZIF series, IRMOF series, MIL series, PCN series, FMOF series or BIO-MOF series.
本发明所述酵母细胞壁的制备方法为:取酵母粉(购自安琪酵母股份有限公司)分散于去离子水中搅拌清洗,离心,取菌体沉淀分散于无水甲醇,搅拌混合均匀,离心,沉淀在50℃干燥,获得酵母细胞壁。The preparation method of the yeast cell wall of the present invention is as follows: take yeast powder (purchased from Angel Yeast Co., Ltd.) and disperse it in deionized water, stir and clean it, centrifuge, take the bacterial cell precipitate and disperse it in anhydrous methanol, stir and mix evenly, centrifuge, The pellet was dried at 50°C to obtain yeast cell walls.
与现有技术相比,本发明的优点:Compared with prior art, the advantages of the present invention:
1.酵母菌细胞壁具有天然的中空结构,且细胞壁为可透过性,具有很好的用于胶囊合成的潜质。1. The cell wall of yeast has a natural hollow structure, and the cell wall is permeable, so it has a good potential for capsule synthesis.
2.所合成的金属有机骨架-细胞壁胶囊的结构能根据合成的条件和过程进行控制。2. The structure of the synthesized MOF-cell wall capsule can be controlled according to the synthesis conditions and process.
3.所合成的金属有机骨架-细胞壁胶囊是超薄的,为数十纳米到数百纳米,该特点能大大的利于该胶囊的应用。3. The synthesized metal-organic framework-cell wall capsule is ultra-thin, ranging from tens of nanometers to hundreds of nanometers, which can greatly benefit the application of the capsule.
4.可以通过控制浸泡配体和金属盐溶液的顺序控制金属有机骨架层是生长在细胞壁内表面和外表面。4. It is possible to control whether the metal-organic framework layer grows on the inner surface and the outer surface of the cell wall by controlling the order of soaking the ligand and the metal salt solution.
5.合成的金属有机骨架-细胞壁胶囊有很好的耐溶剂性能以及很好的机械强度。5. The synthesized metal-organic framework-cell wall capsule has good solvent resistance and good mechanical strength.
(四)附图说明(4) Description of drawings
图1是本发明实施例1合成的ZIF-8-酵母菌细胞壁胶囊的扫描电镜(A)与显微镜图(B)。Fig. 1 is a scanning electron microscope (A) and a microscope image (B) of the ZIF-8-yeast cell wall capsule synthesized in Example 1 of the present invention.
图2是本发明实施例2合成的MIL-53-酵母菌细胞壁胶囊的显微镜图。Fig. 2 is a micrograph of the MIL-53-yeast cell wall capsule synthesized in Example 2 of the present invention.
(五)具体实施方式(5) Specific implementation methods
下面结合具体实施例对本发明进行进一步描述,但本发明的保护范围并不仅限于此:The present invention is further described below in conjunction with specific embodiment, but protection scope of the present invention is not limited thereto:
实施例1:Example 1:
ZIF-8-酵母细胞壁胶囊的合成Synthesis of ZIF-8-Yeast Cell Wall Capsules
(1)取0.05g的酵母粉(购自安琪酵母股份有限公司)分散于去离子水中搅拌清洗,离心后备用。(1) Disperse 0.05 g of yeast powder (purchased from Angel Yeast Co., Ltd.) in deionized water, stir and wash, centrifuge and set aside.
(2)将步骤(1)获得的菌体分散于无水甲醇,搅拌混合均匀,之后离心,沉淀在50℃干燥,获得酵母细胞壁。并将获得的该细胞壁分散于10mL无水甲醇中,获得酵母细胞壁悬浮液。(2) Disperse the bacterial cells obtained in step (1) in anhydrous methanol, stir and mix evenly, then centrifuge, and dry the precipitate at 50° C. to obtain yeast cell walls. The obtained cell wall was dispersed in 10 mL of anhydrous methanol to obtain a yeast cell wall suspension.
(3)取0.5mmol的Zn(NO3)2·6H2O溶于10mL上述酵母细胞壁悬浮液,置于50℃的情况下搅拌12h,使得金属离子进入到细胞壁的内腔中,离心,获得含有金属离子的细胞壁。(3) Dissolve 0.5 mmol of Zn(NO 3 ) 2 ·6H 2 O in 10 mL of the above yeast cell wall suspension, place it at 50°C and stir for 12 hours, so that the metal ions enter the inner cavity of the cell wall, and centrifuge to obtain Cell walls that contain metal ions.
(4)配置50mmol/L的2-甲基咪唑甲醇溶液,将含有金属离子的细胞壁分散于50mmol/L2-甲基咪唑甲醇溶液中,在50℃的情况下搅拌12小时结晶,让结晶后的悬浮液在室温(25℃)下冷却,之后在5000转/分钟的条件下离心5min,去除上清液,收集沉淀物,获得金属有机骨架-细胞壁胶囊,将胶囊60℃烘干备用。(4) Configure 50mmol/L 2-methylimidazole methanol solution, disperse the cell wall containing metal ions in 50mmol/L 2-methylimidazole methanol solution, stir and crystallize for 12 hours at 50°C, let the crystallized The suspension was cooled at room temperature (25°C), then centrifuged at 5000 rpm for 5 minutes, the supernatant was removed, and the precipitate was collected to obtain metal-organic framework-cell wall capsules, which were dried at 60°C for use.
为检验所合成的胶囊的连续性和机械性能,步骤(2)中的Zn(NO3)2·6H2O酵母细胞壁悬浮液和步骤(3)中的2-甲基咪唑甲醇溶液加入玫瑰红染料,最终浓度为0.1g/L,这样所合成的胶囊内部会含有玫瑰红分子;将含有玫瑰红分子的金属有机骨架-细胞壁胶囊用甲醇清洗一遍,并置于甲醇中搅拌,同时检测甲醇中的玫瑰红含量;其含量几乎为零;当在甲醇中加入盐酸时,溶液马上变红,这表明合成的胶囊壁是连续的。将含有玫瑰红分子的金属有机骨架-细胞壁胶囊用甲醇清洗后置于甲醇中搅拌超声,经紫外可见光谱仪检测只有20%的玫瑰红被释放,这表明该胶囊有很好的机械强度,是抗超声分解的。得到的金属有机骨架-细胞壁胶囊如图1所示。可以看到一层连续的金属有机骨架生长于酵母菌细胞壁的表面。金属骨架的厚度在60-90nm之间。To test the continuity and mechanical properties of the synthesized capsules, the Zn(NO 3 ) 2 ·6H 2 O yeast cell wall suspension in step (2) and the 2-methylimidazole methanol solution in step (3) were added with Rose Dye, the final concentration is 0.1g/L, so that the inside of the synthesized capsule will contain rose bengal molecules; the metal organic framework-cell wall capsules containing rose bengal molecules are washed with methanol, and placed in methanol for stirring, while detection of methanol The content of rose bengal; its content is almost zero; when hydrochloric acid is added to methanol, the solution turns red immediately, which indicates that the synthesized capsule wall is continuous. The metal-organic framework-cell wall capsules containing rose bengal molecules were washed with methanol and then placed in methanol and stirred for ultrasonication. Only 20% of rose bengal was released by ultraviolet-visible spectrometer, which indicated that the capsules had good mechanical strength and were resistant to sonicated. The obtained metal-organic framework-cell wall capsule is shown in Figure 1 . A continuous metal-organic framework can be seen growing on the surface of the yeast cell wall. The thickness of the metal skeleton is between 60-90nm.
实施例2:Example 2:
MIL-53-酵母细胞壁胶囊的合成Synthesis of MIL-53-Yeast Cell Wall Capsules
(1)取0.05g的酵母粉分散于去离子水中,搅拌清洗,离心后备用。(1) Take 0.05g of yeast powder and disperse in deionized water, stir and wash, centrifuge and set aside.
(2)将获得的菌体分散于无水甲醇中搅拌并离心,沉淀用N,N-二甲基甲酰胺清洗三次,60℃干燥,获得酵母细胞壁。将获得的酵母细胞壁分散于10mL N,N-二甲基甲酰胺中,获得细胞壁悬浮液。(2) The obtained bacteria were dispersed in anhydrous methanol, stirred and centrifuged, and the precipitate was washed three times with N,N-dimethylformamide, and dried at 60° C. to obtain yeast cell walls. The obtained yeast cell walls were dispersed in 10 mL of N,N-dimethylformamide to obtain a cell wall suspension.
(3)取0.5mmol的FeCl3·6H2O溶于10mL上述细胞壁悬浮液,置于100℃的情况下搅拌12h,使得金属离子进入到细胞壁的内腔中,离心获得含有金属离子的细胞壁。(3) Dissolve 0.5 mmol of FeCl 3 ·6H 2 O in 10 mL of the above cell wall suspension, place at 100° C. and stir for 12 hours, so that metal ions enter the inner cavity of the cell wall, and centrifuge to obtain cell walls containing metal ions.
(4)配置50mmol/L的对苯二甲酸N,N-二甲基甲酰胺溶液,将含有金属离子的细胞壁分散于该溶液中,在100℃的情况下搅拌结晶,让结晶后的悬浮液在室温下冷却,之后在5000转/分钟的条件下离心5min,去除上清液,收集沉淀物,获得金属有机骨架-细胞壁胶囊,将胶囊100℃烘干备用。(4) Configure 50mmol/L terephthalic acid N,N-dimethylformamide solution, disperse the cell wall containing metal ions in the solution, stir and crystallize at 100°C, let the crystallized suspension Cool at room temperature, then centrifuge at 5000 rpm for 5 min, remove the supernatant, collect the precipitate, obtain metal organic framework-cell wall capsules, and dry the capsules at 100°C for use.
得到的金属有机骨架-细胞壁胶囊如图2所示。可以明显看到膜的中空结构。经实施例1所述方法检测,在搅拌的情况下,玫瑰红几乎不释放,表明合成的胶囊壁是连续的;在超声的情况下,只有10%的玫瑰红被释放,这表明合成的胶囊有很好的机械强度,是抗超声分解的。合成的胶囊金属有机骨架层的厚度为40-60nm。The obtained MOF-cell wall capsule is shown in Figure 2. The hollow structure of the membrane can be clearly seen. Detected by the method described in Example 1, under the condition of stirring, rose bengal is hardly released, indicating that the capsule wall of synthesis is continuous; under the situation of ultrasound, only 10% of rose bengal is released, which indicates that the synthetic capsule wall It has good mechanical strength and is resistant to ultrasonic decomposition. The thickness of the synthesized capsule metal-organic framework layer is 40-60nm.
实施例3:Example 3:
CuBTC-酵母细胞壁胶囊的合成Synthesis of CuBTC-Yeast Cell Wall Capsules
(1)取0.05g的酵母粉分散于去离子水中,搅拌清洗,离心后备用。(1) Take 0.05g of yeast powder and disperse in deionized water, stir and wash, centrifuge and set aside.
(2)将获得的菌体分散于无水甲醇中,搅拌并离心,沉淀用去离子水清洗三次,获得酵母菌细胞壁,50℃干燥备用。并将获得的该细胞壁分散于去离子水中,获得细胞壁悬浮液。(2) The obtained bacteria were dispersed in anhydrous methanol, stirred and centrifuged, and the precipitate was washed three times with deionized water to obtain yeast cell walls, and dried at 50° C. for later use. The obtained cell wall was dispersed in deionized water to obtain a cell wall suspension.
(3)取0.5mmol的Cu(NO3)2·6H2O溶于10mL上述细胞壁悬浮液,置于50℃的情况下搅拌12h,使得金属离子进入到细胞壁的内腔中,离心,获得含有金属离子的细胞壁。(3) Dissolve 0.5 mmol of Cu(NO 3 ) 2 ·6H 2 O in 10 mL of the above cell wall suspension, stir at 50°C for 12 hours, so that the metal ions enter the inner cavity of the cell wall, and centrifuge to obtain metal ions in the cell wall.
(4)配置50mmol/L的均苯三甲酸乙醇溶液,将含有金属离子的细胞壁分散于该溶液中,在50℃的情况下搅拌,结晶,让结晶后的悬浮液在室温下冷却,之后在5000转/分钟的条件下离心5min,去除上清液,收集沉淀物,获得金属有机骨架-细胞壁胶囊,将胶囊60℃烘干备用。经实施例1所述方法检测,在搅拌的情况下,玫瑰红几乎不释放;在超声的情况下,只有15%的玫瑰红被释放;这表明合成的胶囊壁是连续的,且有很好的机械强度,是抗超声分解的。合成的胶囊金属有机骨架层的厚度为70-100nm。(4) Configure 50mmol/L trimesic acid ethanol solution, disperse the cell wall containing metal ions in the solution, stir at 50°C, crystallize, allow the crystallized suspension to cool at room temperature, and then Centrifuge at 5000 rpm for 5 min, remove the supernatant, collect the precipitate, and obtain the metal-organic framework-cell wall capsule, and dry the capsule at 60°C for use. Detected by the method described in Example 1, under the condition of stirring, rose bengal is hardly released; under the situation of ultrasound, only 15% of rose bengal is released; this shows that the synthetic capsule wall is continuous and has a good Excellent mechanical strength and is resistant to ultrasonic decomposition. The thickness of the synthesized capsule metal-organic framework layer is 70-100nm.
实施例4:Example 4:
ZIF-8-酵母细胞壁胶囊的合成Synthesis of ZIF-8-Yeast Cell Wall Capsules
(1)取0.05g的酵母粉分散于去离子水中,搅拌清洗,离心后备用。(1) Take 0.05g of yeast powder and disperse in deionized water, stir and wash, centrifuge and set aside.
(2)将获得的菌体分散于无水甲醇,搅拌并离心,获得酵母细胞壁,将其50℃干燥备用。并将获得的该细胞壁分散于10mL甲醇中获得酵母细胞壁悬浮液。(2) The obtained bacteria were dispersed in anhydrous methanol, stirred and centrifuged to obtain yeast cell walls, which were dried at 50° C. for future use. The obtained cell wall was dispersed in 10 mL of methanol to obtain a yeast cell wall suspension.
(3)取1mmol的2-甲基咪唑溶于10mL上述细胞壁悬浮液,置于50℃的情况下搅拌12h,使得2-甲基咪唑进入到细胞壁的内腔中,离心获得含有2-甲基咪唑的细胞壁。(3) Dissolve 1 mmol of 2-methylimidazole in 10 mL of the above-mentioned cell wall suspension, and stir for 12 hours at 50°C, so that 2-methylimidazole enters the inner cavity of the cell wall, and centrifuge to obtain a solution containing 2-methylimidazole. imidazole cell wall.
(4)配置100mmol/L的Zn(NO3)2·6H2O甲醇溶液,将含有2-甲基咪唑的细胞壁分散于Zn(NO3)2·6H2O甲醇溶液中,在50℃的情况下搅拌12小时结晶,让结晶后的悬浮液在室温下冷却,之后在5000转/分钟的条件下离心5min,去除上清液,收集沉淀物,获得金属有机骨架-细胞壁胶囊,将胶囊60℃烘干备用。经实施例1所述方法检测,在搅拌的情况下,玫瑰红几乎不释放;在超声的情况下,只有12%的玫瑰红被释放;这表明合成的胶囊壁是连续的,且有很好的机械强度,是抗超声分解的。合成的胶囊金属有机骨架层的厚度为100-130nm。(4) Prepare 100mmol/L Zn(NO 3 ) 2 ·6H 2 O methanol solution, disperse the cell wall containing 2-methylimidazole in Zn(NO 3 ) 2 ·6H 2 O methanol solution, Stir for 12 hours to crystallize, let the crystallized suspension cool at room temperature, then centrifuge at 5000 rpm for 5 min, remove the supernatant, collect the precipitate, and obtain the metal-organic framework-cell wall capsule. The capsule is 60 °C for drying. Detected by the method described in Example 1, under the condition of stirring, rose bengal is hardly released; under the situation of ultrasound, only 12% of rose bengal is released; this shows that the synthetic capsule wall is continuous and has a good Excellent mechanical strength and is resistant to ultrasonic decomposition. The thickness of the synthesized capsule metal-organic framework layer is 100-130nm.
实施例5:Example 5:
ZIF-8-酵母细胞壁胶囊的合成Synthesis of ZIF-8-Yeast Cell Wall Capsules
(1)取0.05g的酵母粉分散于去离子水中,搅拌清洗,离心后备用。(1) Take 0.05g of yeast powder and disperse in deionized water, stir and wash, centrifuge and set aside.
(2)将获得的菌体分散于无水甲醇,搅拌并离心,获得酵母细胞壁,50℃干燥备用。(2) Disperse the obtained bacterial cells in anhydrous methanol, stir and centrifuge to obtain yeast cell walls, and dry them at 50° C. for later use.
(3)取1mmol的2-甲基咪唑和1mmol Zn(NO3)2·6H2O溶于10ml甲醇中,将制备的细胞壁分散于上述甲醇溶液中,在50℃的情况下搅拌结晶,让结晶后的悬浮液在室温下冷却,之后在5000转/分钟的条件下离心5min,去除上清液,收集沉淀物,获得金属有机骨架-细胞壁胶囊,将胶囊60℃烘干备用。(3) Dissolve 1 mmol of 2-methylimidazole and 1 mmol of Zn(NO 3 ) 2 ·6H 2 O in 10 ml of methanol, disperse the prepared cell wall in the above methanol solution, stir and crystallize at 50°C, let The crystallized suspension was cooled at room temperature, then centrifuged at 5000 rpm for 5 min, the supernatant was removed, and the precipitate was collected to obtain metal-organic framework-cell wall capsules, which were dried at 60°C for use.
为检验所合成的胶囊的连续性和机械性能,步骤(3)中的甲醇溶液加入玫瑰红染料,最终浓度为0.1g/L,这样所合成的胶囊内部会含有玫瑰红分子;将含有玫瑰红分子的金属有机骨架-细胞壁胶囊用甲醇清洗一遍,并置于甲醇溶剂中搅拌,同时检测甲醇溶剂中的玫瑰红含量;其含量几乎为零;当在甲醇溶剂中加入盐酸时,溶液马上变红,这表明合成的胶囊壁是连续的。将含有玫瑰红分子的金属有机骨架-细胞壁胶囊用甲醇清洗后置于甲醇溶剂中搅拌超声,经紫外可见光谱仪检测只有6%的玫瑰红被释放,这表明该胶囊有很好的机械强度,是抗超声分解的。金属骨架的厚度在300-500nm之间。In order to check the continuity and mechanical properties of the synthesized capsule, the methanol solution in step (3) is added with rose bengal dye, and the final concentration is 0.1g/L, so that the inside of the synthesized capsule will contain rose bengal molecules; will contain rose bengal Molecular metal-organic framework-cell wall capsules were cleaned with methanol, and placed in methanol solvent for stirring, while detecting the content of rose bengal in methanol solvent; its content was almost zero; when hydrochloric acid was added to methanol solvent, the solution immediately turned red , which indicates that the synthesized capsule walls are continuous. The metal-organic framework-cell wall capsules containing rose bengal molecules were cleaned with methanol and then placed in methanol solvent for stirring and ultrasonication. Only 6% of rose bengal was released by ultraviolet-visible spectrometer, which indicated that the capsules had good mechanical strength and were Resistant to sonication. The thickness of the metal framework is between 300-500nm.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510147358.1A CN104759242B (en) | 2015-03-31 | 2015-03-31 | A kind of method utilizing yeast synthesis metallic organic framework hollow structure capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510147358.1A CN104759242B (en) | 2015-03-31 | 2015-03-31 | A kind of method utilizing yeast synthesis metallic organic framework hollow structure capsule |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104759242A CN104759242A (en) | 2015-07-08 |
CN104759242B true CN104759242B (en) | 2016-12-07 |
Family
ID=53641531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510147358.1A Active CN104759242B (en) | 2015-03-31 | 2015-03-31 | A kind of method utilizing yeast synthesis metallic organic framework hollow structure capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104759242B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114432979B (en) * | 2020-10-31 | 2023-04-07 | 中国石油化工股份有限公司 | Phase-change microcapsule with metal organic framework material as capsule wall |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69113682T2 (en) * | 1990-06-05 | 1996-03-21 | Kirin Brewery | Process for the production of microcapsules. |
GB9509937D0 (en) * | 1995-05-17 | 1995-07-12 | Cpc International Inc | Encapsulated product |
JP2777981B2 (en) * | 1995-09-12 | 1998-07-23 | 工業技術院長 | Hollow spherical material composed of chitosan-containing fiber and method for producing the same |
GB2424408A (en) * | 2005-03-24 | 2006-09-27 | Micap Plc | Encapsulation using microbial cells |
CN100389754C (en) * | 2005-10-25 | 2008-05-28 | 天津大学 | Method for preparing microcapsules using beer waste yeast cells as wall material |
CN100544815C (en) * | 2007-07-01 | 2009-09-30 | 石国荣 | A method for preparing safe, non-toxic and excellent microcapsule wall material by using yeast cells |
-
2015
- 2015-03-31 CN CN201510147358.1A patent/CN104759242B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104759242A (en) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shaikh et al. | Synthesis and defect characterization of phase-pure Zr-MOFs based on meso-tetracarboxyphenylporphyrin | |
CN103446893B (en) | Method for preparing metal organic framework membrane on inner wall of tubular ceramic support | |
Ji et al. | Tunable cage-based three-dimensional covalent organic frameworks | |
Ding et al. | Improving MOF stability: approaches and applications | |
Nagata et al. | Metal–organic framework tethering PNIPAM for ON–OFF controlled release in solution | |
CN107159130B (en) | A kind of preparation method of metal-organic framework fiber membrane | |
CN102220626B (en) | Method for preparing nano-sized zeolite metal-organic framework compound crystals by dynamic crystallization | |
CN104415670B (en) | Metal organic framework membrane and preparation method and application thereof | |
Li et al. | Microwave-assisted synthesis of UIO-66 and its adsorption performance towards dyes | |
Guo et al. | Water sensitivity in Zn4O-based MOFs is structure and history dependent | |
Guo et al. | Combining coordination modulation with acid–base adjustment for the control over size of metal–organic frameworks | |
He et al. | Synthesis of zeolitic imidazolate framework-7 in a water/ethanol mixture and its ethanol-induced reversible phase transition | |
Khalil et al. | Enabling solution processable COFs through suppression of precipitation during solvothermal synthesis | |
CN101805361B (en) | Double-shell hollow spherical organic metal framework material and preparation method thereof | |
CN107469648B (en) | A kind of preparation method of polytetrafluoroethylene hollow fiber composite membrane | |
CN107029670A (en) | A kind of metal organic framework moulding material and its forming method | |
CN106000351A (en) | Preparation and adsorption application of novel micro-porous ball based on ZIF (Co<2+>) metal organic framework material | |
CN113750968B (en) | Water-insoluble cyclodextrin-based metal organic framework material and preparation method thereof | |
CN112979978B (en) | A kind of ultra-microporous hydrophobic UiO-66 zirconium metal organic framework material and its preparation method and application | |
Moeinian et al. | How the guest molecules in nanoporous Zn (II) metal-organic framework can prevent agglomeration of ZnO nanoparticles | |
CN113150303B (en) | A kind of metal-organic framework material ZIF-67 and preparation method thereof | |
CN103203207A (en) | Magnetic nano-pore metal-organic framework core-shell material preparation, functionalized design, and application. | |
CN104772088A (en) | Template-free preparation method of hollow micro-spherical polymers with covalent organic frameworks (COFs) | |
Jiang et al. | Confined facilitated transport within covalent organic frameworks for propylene/propane membrane separation | |
CN106883419A (en) | A kind of fast synthesis method of cobalt-based metal-organic framework materials and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |